World

About 18,500 Koreans get COVID-19 vaccines on vaccination Day 1

Feb 27, 2021

Seoul (South Korea), February 27: About 18,500 people received a vaccination for COVID-19 in South Korea on the launch day of the nation's public vaccination campaign against the pandemic, a government agency said Saturday.
According to the Central Disaster and Safety Countermeasure Headquarters, 18,489 people across the country got their first shots of the two-dose AstraZeneca vaccine Friday.
"On Friday, 18,489 medical workers, health care workers and nursing home patients received the AstraZeneca vaccine at community health centers and 213 nursing facilities in 17 metropolitan cities and provinces as planned," said Jeon Hae-cheol, minister of the Interior and Safety, in an agency meeting.
The minister noted there have been no reports of specific adverse reactions from vaccine recipients, except for mild symptoms, such as headaches and fever.
The first day tally of vaccinations represents 6.39 percent of 289,480 health care workers and patients under 65 years of age who had agreed to the vaccination. It also accounts for 0.04 percent of the nation's population of 52 million.
By region, Gyeonggi Province, which surrounds Seoul, accounted for 3,532 of the Day 1 vaccine recipients, followed by 3,072 in Gwangju and 1,922 in the capital.
The administering of Pfizer's vaccine also began at the National Medical Center in Seoul on Saturday. The first shipment of 58,500 doses of Pfizer's vaccine arrived in Korea on Friday and an additional 500,000 doses are due to arrive at the beginning of the third week of March.
About 300 medical and other workers -- 199 from the National Medical Center and 101 from other hospitals specializing in the treatment of COVID-19 patients -- are to receive the Pfizer vaccine.
The nation's first recipient of the Pfizer vaccine was a 51-year-old sanitation worker of the National Medical Center, named Chung Mi-kyeong, who got the shot at 9:04 a.m., according to government officials.
Source: Yonhap

More news

Ruskle Secures Seed Funding from DLabs at the Indian School of Business

New Delhi [India], April 18: Ruskle, the pioneering brand in flavored rusks for tea time snacking, today announced that it has raised INR 25 Lakhs in seed funding from DLabs at the Indian School of Business, through the Startup India Seed Fund Scheme (SISFS). This investment marks a significant milestone for Ruskle, propelling its expansion pan-India (especially ithe Northern markets) and solidifying its position as a frontrunner in the snacking industry.

Apr 18, 2024